Global Belzutifan Market Growth 2026-2032
The global Belzutifan market size is predicted to grow from US$ 685 million in 2025 to US$ 1610 million in 2032; it is expected to grow at a CAGR of 10.6% from 2026 to 2032.
In 2025, global Belzutifan production reached approximately 42,000 units.Belzutifan is an orally administered small-molecule hypoxia-inducible factor-2 alpha (HIF-2?) inhibitor used for the treatment of tumor diseases associated with abnormalities in the hypoxia signaling pathway. The drug selectively inhibits HIF-2? transcriptional activity, thereby reducing the expression of downstream pro-tumor genes, such as those involved in angiogenesis and cell proliferation, ultimately suppressing tumor growth and slowing disease progression. Belzutifan is primarily indicated for the treatment of von Hippel-Lindau (VHL) disease-associated tumors and advanced renal cell carcinoma (RCC), and it represents an important emerging innovative therapy targeting tumor metabolism and hypoxia pathways.
Belzutifan, as the first approved HIF-2? inhibitor, is positioned in the early high-growth stage of the emerging targeted oncology therapy market. It is primarily used in the treatment of von Hippel-Lindau (VHL) disease-associated tumors and advanced renal cell carcinoma (RCC). In recent years, with the advancement of precision oncology and the further elucidation of the role of hypoxia signaling pathways in tumorigenesis, the HIF-2? target has become an important direction for next-generation anticancer drug development. Against this backdrop, Belzutifan has established a first-mover advantage in the market due to its innovative mechanism and demonstrated efficacy in VHL-associated tumors. However, the field is still in an early stage of commercialization, with a relatively limited patient population and an incompletely realized market potential. At the same time, it faces competitive pressure from VEGF inhibitors and immunotherapy-based combination regimens. Therefore, its future market growth will largely depend on indication expansion, development of combination therapies, and increased penetration in larger indications such as renal cell carcinoma.
LP Information, Inc. (LPI) ' newest research report, the ?Belzutifan Industry Forecast? looks at past sales and reviews total world Belzutifan sales in 2025, providing a comprehensive analysis by region and market sector of projected Belzutifan sales for 2026 through 2032. With Belzutifan sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Belzutifan industry.
This Insight Report provides a comprehensive analysis of the global Belzutifan landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Belzutifan portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Belzutifan market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Belzutifan and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Belzutifan.
This report presents a comprehensive overview, market shares, and growth opportunities of Belzutifan market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Belzutifan market?
What factors are driving Belzutifan market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Belzutifan market opportunities vary by end market size?
How does Belzutifan break out by Type, by Application?
In 2025, global Belzutifan production reached approximately 42,000 units.Belzutifan is an orally administered small-molecule hypoxia-inducible factor-2 alpha (HIF-2?) inhibitor used for the treatment of tumor diseases associated with abnormalities in the hypoxia signaling pathway. The drug selectively inhibits HIF-2? transcriptional activity, thereby reducing the expression of downstream pro-tumor genes, such as those involved in angiogenesis and cell proliferation, ultimately suppressing tumor growth and slowing disease progression. Belzutifan is primarily indicated for the treatment of von Hippel-Lindau (VHL) disease-associated tumors and advanced renal cell carcinoma (RCC), and it represents an important emerging innovative therapy targeting tumor metabolism and hypoxia pathways.
Belzutifan, as the first approved HIF-2? inhibitor, is positioned in the early high-growth stage of the emerging targeted oncology therapy market. It is primarily used in the treatment of von Hippel-Lindau (VHL) disease-associated tumors and advanced renal cell carcinoma (RCC). In recent years, with the advancement of precision oncology and the further elucidation of the role of hypoxia signaling pathways in tumorigenesis, the HIF-2? target has become an important direction for next-generation anticancer drug development. Against this backdrop, Belzutifan has established a first-mover advantage in the market due to its innovative mechanism and demonstrated efficacy in VHL-associated tumors. However, the field is still in an early stage of commercialization, with a relatively limited patient population and an incompletely realized market potential. At the same time, it faces competitive pressure from VEGF inhibitors and immunotherapy-based combination regimens. Therefore, its future market growth will largely depend on indication expansion, development of combination therapies, and increased penetration in larger indications such as renal cell carcinoma.
LP Information, Inc. (LPI) ' newest research report, the ?Belzutifan Industry Forecast? looks at past sales and reviews total world Belzutifan sales in 2025, providing a comprehensive analysis by region and market sector of projected Belzutifan sales for 2026 through 2032. With Belzutifan sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Belzutifan industry.
This Insight Report provides a comprehensive analysis of the global Belzutifan landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Belzutifan portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Belzutifan market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Belzutifan and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Belzutifan.
This report presents a comprehensive overview, market shares, and growth opportunities of Belzutifan market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 40 mg tablets
- 120 mg tablets
- Hospital
- Retail
- Online
- With VEGF Inhibitors in Combination Therapy
- With Immune Checkpoint Inhibitors in Combination Therapy
- Originator
- Generic
- Von Hippel-Lindau (VHL) Disease-Associated Renal Cell Carcinoma (RCC)
- Von Hippel-Lindau (VHL) Disease-Associated Central Nervous System Hemangioblastomas
- Von Hippel-Lindau (VHL) Disease-Associated Pancreatic Neuroendocrine Tumors (pNET)
- Pheochromocytoma and Paraganglioma (PPGL) Associated with VHL Disease
- Otherts
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck & Co
- Peloton Therapeutics
What is the 10-year outlook for the global Belzutifan market?
What factors are driving Belzutifan market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Belzutifan market opportunities vary by end market size?
How does Belzutifan break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Belzutifan Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Belzutifan by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Belzutifan by Country/Region, 2021, 2025 & 2032
2.2 Belzutifan Segment by Type
2.2.1 40 mg tablets
2.2.2 120 mg tablets
2.2.3 Belzutifan Sales by Type
2.2.3.1 Global Belzutifan Sales Market Share by Type (2021-2026)
2.2.3.2 Global Belzutifan Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Belzutifan Sale Price by Type (2021-2026)
2.3 Belzutifan Segment by Sales Channels
2.3.1 Hospital
2.3.2 Retail
2.3.3 Online
2.3.4 Belzutifan Sales by Sales Channels
2.3.4.1 Global Belzutifan Sales Market Share by Sales Channels (2021-2026)
2.3.4.2 Global Belzutifan Revenue and Market Share by Sales Channels (2021-2026)
2.3.4.3 Global Belzutifan Sale Price by Sales Channels (2021-2026)
2.4 Belzutifan Segment by Combination Therapy
2.4.1 With VEGF Inhibitors in Combination Therapy
2.4.2 With Immune Checkpoint Inhibitors in Combination Therapy
2.4.3 Belzutifan Sales by Combination Therapy
2.4.3.1 Global Belzutifan Sales Market Share by Combination Therapy (2021-2026)
2.4.3.2 Global Belzutifan Revenue and Market Share by Combination Therapy (2021-2026)
2.4.3.3 Global Belzutifan Sale Price by Combination Therapy (2021-2026)
2.5 Belzutifan Segment by Production Technology
2.5.1 Originator
2.5.2 Generic
2.5.3 Belzutifan Sales by Production Technology
2.5.3.1 Global Belzutifan Sales Market Share by Production Technology (2021-2026)
2.5.3.2 Global Belzutifan Revenue and Market Share by Production Technology (2021-2026)
2.5.3.3 Global Belzutifan Sale Price by Production Technology (2021-2026)
2.6 Belzutifan Segment by Application
2.6.1 Von Hippel-Lindau (VHL) Disease-Associated Renal Cell Carcinoma (RCC)
2.6.2 Von Hippel-Lindau (VHL) Disease-Associated Central Nervous System Hemangioblastomas
2.6.3 Von Hippel-Lindau (VHL) Disease-Associated Pancreatic Neuroendocrine Tumors (pNET)
2.6.4 Pheochromocytoma and Paraganglioma (PPGL) Associated with VHL Disease
2.6.5 Otherts
2.6.6 Belzutifan Sales by Application
2.6.6.1 Global Belzutifan Sale Market Share by Application (2021-2026)
2.6.6.2 Global Belzutifan Revenue and Market Share by Application (2021-2026)
2.6.6.3 Global Belzutifan Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Belzutifan Breakdown Data by Company
3.1.1 Global Belzutifan Annual Sales by Company (2021-2026)
3.1.2 Global Belzutifan Sales Market Share by Company (2021-2026)
3.2 Global Belzutifan Annual Revenue by Company (2021-2026)
3.2.1 Global Belzutifan Revenue by Company (2021-2026)
3.2.2 Global Belzutifan Revenue Market Share by Company (2021-2026)
3.3 Global Belzutifan Sale Price by Company
3.4 Key Manufacturers Belzutifan Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Belzutifan Product Location Distribution
3.4.2 Players Belzutifan Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BELZUTIFAN BY GEOGRAPHIC REGION
4.1 World Historic Belzutifan Market Size by Geographic Region (2021-2026)
4.1.1 Global Belzutifan Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Belzutifan Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Belzutifan Market Size by Country/Region (2021-2026)
4.2.1 Global Belzutifan Annual Sales by Country/Region (2021-2026)
4.2.2 Global Belzutifan Annual Revenue by Country/Region (2021-2026)
4.3 Americas Belzutifan Sales Growth
4.4 APAC Belzutifan Sales Growth
4.5 Europe Belzutifan Sales Growth
4.6 Middle East & Africa Belzutifan Sales Growth
5 AMERICAS
5.1 Americas Belzutifan Sales by Country
5.1.1 Americas Belzutifan Sales by Country (2021-2026)
5.1.2 Americas Belzutifan Revenue by Country (2021-2026)
5.2 Americas Belzutifan Sales by Type (2021-2026)
5.3 Americas Belzutifan Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Belzutifan Sales by Region
6.1.1 APAC Belzutifan Sales by Region (2021-2026)
6.1.2 APAC Belzutifan Revenue by Region (2021-2026)
6.2 APAC Belzutifan Sales by Type (2021-2026)
6.3 APAC Belzutifan Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Belzutifan by Country
7.1.1 Europe Belzutifan Sales by Country (2021-2026)
7.1.2 Europe Belzutifan Revenue by Country (2021-2026)
7.2 Europe Belzutifan Sales by Type (2021-2026)
7.3 Europe Belzutifan Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Belzutifan by Country
8.1.1 Middle East & Africa Belzutifan Sales by Country (2021-2026)
8.1.2 Middle East & Africa Belzutifan Revenue by Country (2021-2026)
8.2 Middle East & Africa Belzutifan Sales by Type (2021-2026)
8.3 Middle East & Africa Belzutifan Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Belzutifan
10.3 Manufacturing Process Analysis of Belzutifan
10.4 Industry Chain Structure of Belzutifan
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Belzutifan Distributors
11.3 Belzutifan Customer
12 WORLD FORECAST REVIEW FOR BELZUTIFAN BY GEOGRAPHIC REGION
12.1 Global Belzutifan Market Size Forecast by Region
12.1.1 Global Belzutifan Forecast by Region (2027-2032)
12.1.2 Global Belzutifan Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Belzutifan Forecast by Type (2027-2032)
12.7 Global Belzutifan Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Merck & Co
13.1.1 Merck & Co Company Information
13.1.2 Merck & Co Belzutifan Product Portfolios and Specifications
13.1.3 Merck & Co Belzutifan Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Merck & Co Main Business Overview
13.1.5 Merck & Co Latest Developments
13.2 Peloton Therapeutics
13.2.1 Peloton Therapeutics Company Information
13.2.2 Peloton Therapeutics Belzutifan Product Portfolios and Specifications
13.2.3 Peloton Therapeutics Belzutifan Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Peloton Therapeutics Main Business Overview
13.2.5 Peloton Therapeutics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Belzutifan Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Belzutifan by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Belzutifan by Country/Region, 2021, 2025 & 2032
2.2 Belzutifan Segment by Type
2.2.1 40 mg tablets
2.2.2 120 mg tablets
2.2.3 Belzutifan Sales by Type
2.2.3.1 Global Belzutifan Sales Market Share by Type (2021-2026)
2.2.3.2 Global Belzutifan Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Belzutifan Sale Price by Type (2021-2026)
2.3 Belzutifan Segment by Sales Channels
2.3.1 Hospital
2.3.2 Retail
2.3.3 Online
2.3.4 Belzutifan Sales by Sales Channels
2.3.4.1 Global Belzutifan Sales Market Share by Sales Channels (2021-2026)
2.3.4.2 Global Belzutifan Revenue and Market Share by Sales Channels (2021-2026)
2.3.4.3 Global Belzutifan Sale Price by Sales Channels (2021-2026)
2.4 Belzutifan Segment by Combination Therapy
2.4.1 With VEGF Inhibitors in Combination Therapy
2.4.2 With Immune Checkpoint Inhibitors in Combination Therapy
2.4.3 Belzutifan Sales by Combination Therapy
2.4.3.1 Global Belzutifan Sales Market Share by Combination Therapy (2021-2026)
2.4.3.2 Global Belzutifan Revenue and Market Share by Combination Therapy (2021-2026)
2.4.3.3 Global Belzutifan Sale Price by Combination Therapy (2021-2026)
2.5 Belzutifan Segment by Production Technology
2.5.1 Originator
2.5.2 Generic
2.5.3 Belzutifan Sales by Production Technology
2.5.3.1 Global Belzutifan Sales Market Share by Production Technology (2021-2026)
2.5.3.2 Global Belzutifan Revenue and Market Share by Production Technology (2021-2026)
2.5.3.3 Global Belzutifan Sale Price by Production Technology (2021-2026)
2.6 Belzutifan Segment by Application
2.6.1 Von Hippel-Lindau (VHL) Disease-Associated Renal Cell Carcinoma (RCC)
2.6.2 Von Hippel-Lindau (VHL) Disease-Associated Central Nervous System Hemangioblastomas
2.6.3 Von Hippel-Lindau (VHL) Disease-Associated Pancreatic Neuroendocrine Tumors (pNET)
2.6.4 Pheochromocytoma and Paraganglioma (PPGL) Associated with VHL Disease
2.6.5 Otherts
2.6.6 Belzutifan Sales by Application
2.6.6.1 Global Belzutifan Sale Market Share by Application (2021-2026)
2.6.6.2 Global Belzutifan Revenue and Market Share by Application (2021-2026)
2.6.6.3 Global Belzutifan Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Belzutifan Breakdown Data by Company
3.1.1 Global Belzutifan Annual Sales by Company (2021-2026)
3.1.2 Global Belzutifan Sales Market Share by Company (2021-2026)
3.2 Global Belzutifan Annual Revenue by Company (2021-2026)
3.2.1 Global Belzutifan Revenue by Company (2021-2026)
3.2.2 Global Belzutifan Revenue Market Share by Company (2021-2026)
3.3 Global Belzutifan Sale Price by Company
3.4 Key Manufacturers Belzutifan Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Belzutifan Product Location Distribution
3.4.2 Players Belzutifan Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BELZUTIFAN BY GEOGRAPHIC REGION
4.1 World Historic Belzutifan Market Size by Geographic Region (2021-2026)
4.1.1 Global Belzutifan Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Belzutifan Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Belzutifan Market Size by Country/Region (2021-2026)
4.2.1 Global Belzutifan Annual Sales by Country/Region (2021-2026)
4.2.2 Global Belzutifan Annual Revenue by Country/Region (2021-2026)
4.3 Americas Belzutifan Sales Growth
4.4 APAC Belzutifan Sales Growth
4.5 Europe Belzutifan Sales Growth
4.6 Middle East & Africa Belzutifan Sales Growth
5 AMERICAS
5.1 Americas Belzutifan Sales by Country
5.1.1 Americas Belzutifan Sales by Country (2021-2026)
5.1.2 Americas Belzutifan Revenue by Country (2021-2026)
5.2 Americas Belzutifan Sales by Type (2021-2026)
5.3 Americas Belzutifan Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Belzutifan Sales by Region
6.1.1 APAC Belzutifan Sales by Region (2021-2026)
6.1.2 APAC Belzutifan Revenue by Region (2021-2026)
6.2 APAC Belzutifan Sales by Type (2021-2026)
6.3 APAC Belzutifan Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Belzutifan by Country
7.1.1 Europe Belzutifan Sales by Country (2021-2026)
7.1.2 Europe Belzutifan Revenue by Country (2021-2026)
7.2 Europe Belzutifan Sales by Type (2021-2026)
7.3 Europe Belzutifan Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Belzutifan by Country
8.1.1 Middle East & Africa Belzutifan Sales by Country (2021-2026)
8.1.2 Middle East & Africa Belzutifan Revenue by Country (2021-2026)
8.2 Middle East & Africa Belzutifan Sales by Type (2021-2026)
8.3 Middle East & Africa Belzutifan Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Belzutifan
10.3 Manufacturing Process Analysis of Belzutifan
10.4 Industry Chain Structure of Belzutifan
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Belzutifan Distributors
11.3 Belzutifan Customer
12 WORLD FORECAST REVIEW FOR BELZUTIFAN BY GEOGRAPHIC REGION
12.1 Global Belzutifan Market Size Forecast by Region
12.1.1 Global Belzutifan Forecast by Region (2027-2032)
12.1.2 Global Belzutifan Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Belzutifan Forecast by Type (2027-2032)
12.7 Global Belzutifan Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Merck & Co
13.1.1 Merck & Co Company Information
13.1.2 Merck & Co Belzutifan Product Portfolios and Specifications
13.1.3 Merck & Co Belzutifan Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Merck & Co Main Business Overview
13.1.5 Merck & Co Latest Developments
13.2 Peloton Therapeutics
13.2.1 Peloton Therapeutics Company Information
13.2.2 Peloton Therapeutics Belzutifan Product Portfolios and Specifications
13.2.3 Peloton Therapeutics Belzutifan Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Peloton Therapeutics Main Business Overview
13.2.5 Peloton Therapeutics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Belzutifan Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Belzutifan Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 40 mg tablets
Table 4. Major Players of 120 mg tablets
Table 5. Global Belzutifan Sales by Type (2021-2026) & (Units)
Table 6. Global Belzutifan Sales Market Share by Type (2021-2026)
Table 7. Global Belzutifan Revenue by Type (2021-2026) & ($ million)
Table 8. Global Belzutifan Revenue Market Share by Type (2021-2026)
Table 9. Global Belzutifan Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Hospital
Table 11. Major Players of Retail
Table 12. Major Players of Online
Table 13. Global Belzutifan Sales by Sales Channels (2021-2026) & (Units)
Table 14. Global Belzutifan Sales Market Share by Sales Channels (2021-2026)
Table 15. Global Belzutifan Revenue by Sales Channels (2021-2026) & ($ million)
Table 16. Global Belzutifan Revenue Market Share by Sales Channels (2021-2026)
Table 17. Global Belzutifan Sale Price by Sales Channels (2021-2026) & (US$/Unit)
Table 18. Major Players of With VEGF Inhibitors in Combination Therapy
Table 19. Major Players of With Immune Checkpoint Inhibitors in Combination Therapy
Table 20. Global Belzutifan Sales by Combination Therapy (2021-2026) & (Units)
Table 21. Global Belzutifan Sales Market Share by Combination Therapy (2021-2026)
Table 22. Global Belzutifan Revenue by Combination Therapy (2021-2026) & ($ million)
Table 23. Global Belzutifan Revenue Market Share by Combination Therapy (2021-2026)
Table 24. Global Belzutifan Sale Price by Combination Therapy (2021-2026) & (US$/Unit)
Table 25. Major Players of Originator
Table 26. Major Players of Generic
Table 27. Global Belzutifan Sales by Production Technology (2021-2026) & (Units)
Table 28. Global Belzutifan Sales Market Share by Production Technology (2021-2026)
Table 29. Global Belzutifan Revenue by Production Technology (2021-2026) & ($ million)
Table 30. Global Belzutifan Revenue Market Share by Production Technology (2021-2026)
Table 31. Global Belzutifan Sale Price by Production Technology (2021-2026) & (US$/Unit)
Table 32. Global Belzutifan Sale by Application (2021-2026) & (Units)
Table 33. Global Belzutifan Sale Market Share by Application (2021-2026)
Table 34. Global Belzutifan Revenue by Application (2021-2026) & ($ million)
Table 35. Global Belzutifan Revenue Market Share by Application (2021-2026)
Table 36. Global Belzutifan Sale Price by Application (2021-2026) & (US$/Unit)
Table 37. Global Belzutifan Sales by Company (2021-2026) & (Units)
Table 38. Global Belzutifan Sales Market Share by Company (2021-2026)
Table 39. Global Belzutifan Revenue by Company (2021-2026) & ($ millions)
Table 40. Global Belzutifan Revenue Market Share by Company (2021-2026)
Table 41. Global Belzutifan Sale Price by Company (2021-2026) & (US$/Unit)
Table 42. Key Manufacturers Belzutifan Producing Area Distribution and Sales Area
Table 43. Players Belzutifan Products Offered
Table 44. Belzutifan Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 45. New Products and Potential Entrants
Table 46. Market M&A Activity & Strategy
Table 47. Global Belzutifan Sales by Geographic Region (2021-2026) & (Units)
Table 48. Global Belzutifan Sales Market Share Geographic Region (2021-2026)
Table 49. Global Belzutifan Revenue by Geographic Region (2021-2026) & ($ millions)
Table 50. Global Belzutifan Revenue Market Share by Geographic Region (2021-2026)
Table 51. Global Belzutifan Sales by Country/Region (2021-2026) & (Units)
Table 52. Global Belzutifan Sales Market Share by Country/Region (2021-2026)
Table 53. Global Belzutifan Revenue by Country/Region (2021-2026) & ($ millions)
Table 54. Global Belzutifan Revenue Market Share by Country/Region (2021-2026)
Table 55. Americas Belzutifan Sales by Country (2021-2026) & (Units)
Table 56. Americas Belzutifan Sales Market Share by Country (2021-2026)
Table 57. Americas Belzutifan Revenue by Country (2021-2026) & ($ millions)
Table 58. Americas Belzutifan Sales by Type (2021-2026) & (Units)
Table 59. Americas Belzutifan Sales by Application (2021-2026) & (Units)
Table 60. APAC Belzutifan Sales by Region (2021-2026) & (Units)
Table 61. APAC Belzutifan Sales Market Share by Region (2021-2026)
Table 62. APAC Belzutifan Revenue by Region (2021-2026) & ($ millions)
Table 63. APAC Belzutifan Sales by Type (2021-2026) & (Units)
Table 64. APAC Belzutifan Sales by Application (2021-2026) & (Units)
Table 65. Europe Belzutifan Sales by Country (2021-2026) & (Units)
Table 66. Europe Belzutifan Revenue by Country (2021-2026) & ($ millions)
Table 67. Europe Belzutifan Sales by Type (2021-2026) & (Units)
Table 68. Europe Belzutifan Sales by Application (2021-2026) & (Units)
Table 69. Middle East & Africa Belzutifan Sales by Country (2021-2026) & (Units)
Table 70. Middle East & Africa Belzutifan Revenue Market Share by Country (2021-2026)
Table 71. Middle East & Africa Belzutifan Sales by Type (2021-2026) & (Units)
Table 72. Middle East & Africa Belzutifan Sales by Application (2021-2026) & (Units)
Table 73. Key Market Drivers & Growth Opportunities of Belzutifan
Table 74. Key Market Challenges & Risks of Belzutifan
Table 75. Key Industry Trends of Belzutifan
Table 76. Belzutifan Raw Material
Table 77. Key Suppliers of Raw Materials
Table 78. Belzutifan Distributors List
Table 79. Belzutifan Customer List
Table 80. Global Belzutifan Sales Forecast by Region (2027-2032) & (Units)
Table 81. Global Belzutifan Revenue Forecast by Region (2027-2032) & ($ millions)
Table 82. Americas Belzutifan Sales Forecast by Country (2027-2032) & (Units)
Table 83. Americas Belzutifan Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. APAC Belzutifan Sales Forecast by Region (2027-2032) & (Units)
Table 85. APAC Belzutifan Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 86. Europe Belzutifan Sales Forecast by Country (2027-2032) & (Units)
Table 87. Europe Belzutifan Revenue Forecast by Country (2027-2032) & ($ millions)
Table 88. Middle East & Africa Belzutifan Sales Forecast by Country (2027-2032) & (Units)
Table 89. Middle East & Africa Belzutifan Revenue Forecast by Country (2027-2032) & ($ millions)
Table 90. Global Belzutifan Sales Forecast by Type (2027-2032) & (Units)
Table 91. Global Belzutifan Revenue Forecast by Type (2027-2032) & ($ millions)
Table 92. Global Belzutifan Sales Forecast by Application (2027-2032) & (Units)
Table 93. Global Belzutifan Revenue Forecast by Application (2027-2032) & ($ millions)
Table 94. Merck & Co Basic Information, Belzutifan Manufacturing Base, Sales Area and Its Competitors
Table 95. Merck & Co Belzutifan Product Portfolios and Specifications
Table 96. Merck & Co Belzutifan Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Merck & Co Main Business
Table 98. Merck & Co Latest Developments
Table 99. Peloton Therapeutics Basic Information, Belzutifan Manufacturing Base, Sales Area and Its Competitors
Table 100. Peloton Therapeutics Belzutifan Product Portfolios and Specifications
Table 101. Peloton Therapeutics Belzutifan Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Peloton Therapeutics Main Business
Table 103. Peloton Therapeutics Latest Developments
Table 1. Belzutifan Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Belzutifan Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 40 mg tablets
Table 4. Major Players of 120 mg tablets
Table 5. Global Belzutifan Sales by Type (2021-2026) & (Units)
Table 6. Global Belzutifan Sales Market Share by Type (2021-2026)
Table 7. Global Belzutifan Revenue by Type (2021-2026) & ($ million)
Table 8. Global Belzutifan Revenue Market Share by Type (2021-2026)
Table 9. Global Belzutifan Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Hospital
Table 11. Major Players of Retail
Table 12. Major Players of Online
Table 13. Global Belzutifan Sales by Sales Channels (2021-2026) & (Units)
Table 14. Global Belzutifan Sales Market Share by Sales Channels (2021-2026)
Table 15. Global Belzutifan Revenue by Sales Channels (2021-2026) & ($ million)
Table 16. Global Belzutifan Revenue Market Share by Sales Channels (2021-2026)
Table 17. Global Belzutifan Sale Price by Sales Channels (2021-2026) & (US$/Unit)
Table 18. Major Players of With VEGF Inhibitors in Combination Therapy
Table 19. Major Players of With Immune Checkpoint Inhibitors in Combination Therapy
Table 20. Global Belzutifan Sales by Combination Therapy (2021-2026) & (Units)
Table 21. Global Belzutifan Sales Market Share by Combination Therapy (2021-2026)
Table 22. Global Belzutifan Revenue by Combination Therapy (2021-2026) & ($ million)
Table 23. Global Belzutifan Revenue Market Share by Combination Therapy (2021-2026)
Table 24. Global Belzutifan Sale Price by Combination Therapy (2021-2026) & (US$/Unit)
Table 25. Major Players of Originator
Table 26. Major Players of Generic
Table 27. Global Belzutifan Sales by Production Technology (2021-2026) & (Units)
Table 28. Global Belzutifan Sales Market Share by Production Technology (2021-2026)
Table 29. Global Belzutifan Revenue by Production Technology (2021-2026) & ($ million)
Table 30. Global Belzutifan Revenue Market Share by Production Technology (2021-2026)
Table 31. Global Belzutifan Sale Price by Production Technology (2021-2026) & (US$/Unit)
Table 32. Global Belzutifan Sale by Application (2021-2026) & (Units)
Table 33. Global Belzutifan Sale Market Share by Application (2021-2026)
Table 34. Global Belzutifan Revenue by Application (2021-2026) & ($ million)
Table 35. Global Belzutifan Revenue Market Share by Application (2021-2026)
Table 36. Global Belzutifan Sale Price by Application (2021-2026) & (US$/Unit)
Table 37. Global Belzutifan Sales by Company (2021-2026) & (Units)
Table 38. Global Belzutifan Sales Market Share by Company (2021-2026)
Table 39. Global Belzutifan Revenue by Company (2021-2026) & ($ millions)
Table 40. Global Belzutifan Revenue Market Share by Company (2021-2026)
Table 41. Global Belzutifan Sale Price by Company (2021-2026) & (US$/Unit)
Table 42. Key Manufacturers Belzutifan Producing Area Distribution and Sales Area
Table 43. Players Belzutifan Products Offered
Table 44. Belzutifan Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 45. New Products and Potential Entrants
Table 46. Market M&A Activity & Strategy
Table 47. Global Belzutifan Sales by Geographic Region (2021-2026) & (Units)
Table 48. Global Belzutifan Sales Market Share Geographic Region (2021-2026)
Table 49. Global Belzutifan Revenue by Geographic Region (2021-2026) & ($ millions)
Table 50. Global Belzutifan Revenue Market Share by Geographic Region (2021-2026)
Table 51. Global Belzutifan Sales by Country/Region (2021-2026) & (Units)
Table 52. Global Belzutifan Sales Market Share by Country/Region (2021-2026)
Table 53. Global Belzutifan Revenue by Country/Region (2021-2026) & ($ millions)
Table 54. Global Belzutifan Revenue Market Share by Country/Region (2021-2026)
Table 55. Americas Belzutifan Sales by Country (2021-2026) & (Units)
Table 56. Americas Belzutifan Sales Market Share by Country (2021-2026)
Table 57. Americas Belzutifan Revenue by Country (2021-2026) & ($ millions)
Table 58. Americas Belzutifan Sales by Type (2021-2026) & (Units)
Table 59. Americas Belzutifan Sales by Application (2021-2026) & (Units)
Table 60. APAC Belzutifan Sales by Region (2021-2026) & (Units)
Table 61. APAC Belzutifan Sales Market Share by Region (2021-2026)
Table 62. APAC Belzutifan Revenue by Region (2021-2026) & ($ millions)
Table 63. APAC Belzutifan Sales by Type (2021-2026) & (Units)
Table 64. APAC Belzutifan Sales by Application (2021-2026) & (Units)
Table 65. Europe Belzutifan Sales by Country (2021-2026) & (Units)
Table 66. Europe Belzutifan Revenue by Country (2021-2026) & ($ millions)
Table 67. Europe Belzutifan Sales by Type (2021-2026) & (Units)
Table 68. Europe Belzutifan Sales by Application (2021-2026) & (Units)
Table 69. Middle East & Africa Belzutifan Sales by Country (2021-2026) & (Units)
Table 70. Middle East & Africa Belzutifan Revenue Market Share by Country (2021-2026)
Table 71. Middle East & Africa Belzutifan Sales by Type (2021-2026) & (Units)
Table 72. Middle East & Africa Belzutifan Sales by Application (2021-2026) & (Units)
Table 73. Key Market Drivers & Growth Opportunities of Belzutifan
Table 74. Key Market Challenges & Risks of Belzutifan
Table 75. Key Industry Trends of Belzutifan
Table 76. Belzutifan Raw Material
Table 77. Key Suppliers of Raw Materials
Table 78. Belzutifan Distributors List
Table 79. Belzutifan Customer List
Table 80. Global Belzutifan Sales Forecast by Region (2027-2032) & (Units)
Table 81. Global Belzutifan Revenue Forecast by Region (2027-2032) & ($ millions)
Table 82. Americas Belzutifan Sales Forecast by Country (2027-2032) & (Units)
Table 83. Americas Belzutifan Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. APAC Belzutifan Sales Forecast by Region (2027-2032) & (Units)
Table 85. APAC Belzutifan Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 86. Europe Belzutifan Sales Forecast by Country (2027-2032) & (Units)
Table 87. Europe Belzutifan Revenue Forecast by Country (2027-2032) & ($ millions)
Table 88. Middle East & Africa Belzutifan Sales Forecast by Country (2027-2032) & (Units)
Table 89. Middle East & Africa Belzutifan Revenue Forecast by Country (2027-2032) & ($ millions)
Table 90. Global Belzutifan Sales Forecast by Type (2027-2032) & (Units)
Table 91. Global Belzutifan Revenue Forecast by Type (2027-2032) & ($ millions)
Table 92. Global Belzutifan Sales Forecast by Application (2027-2032) & (Units)
Table 93. Global Belzutifan Revenue Forecast by Application (2027-2032) & ($ millions)
Table 94. Merck & Co Basic Information, Belzutifan Manufacturing Base, Sales Area and Its Competitors
Table 95. Merck & Co Belzutifan Product Portfolios and Specifications
Table 96. Merck & Co Belzutifan Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Merck & Co Main Business
Table 98. Merck & Co Latest Developments
Table 99. Peloton Therapeutics Basic Information, Belzutifan Manufacturing Base, Sales Area and Its Competitors
Table 100. Peloton Therapeutics Belzutifan Product Portfolios and Specifications
Table 101. Peloton Therapeutics Belzutifan Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Peloton Therapeutics Main Business
Table 103. Peloton Therapeutics Latest Developments
LIST OF FIGURES
Figure 1. Picture of Belzutifan
Figure 2. Belzutifan Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Belzutifan Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Belzutifan Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Belzutifan Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Belzutifan Sales Market Share by Country/Region (2025)
Figure 10. Belzutifan Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 40 mg tablets
Figure 12. Product Picture of 120 mg tablets
Figure 13. Global Belzutifan Sales Market Share by Type in 2026
Figure 14. Global Belzutifan Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Hospital
Figure 16. Product Picture of Retail
Figure 17. Product Picture of Online
Figure 18. Global Belzutifan Sales Market Share by Sales Channels in 2026
Figure 19. Global Belzutifan Revenue Market Share by Sales Channels (2021-2026)
Figure 20. Product Picture of With VEGF Inhibitors in Combination Therapy
Figure 21. Product Picture of With Immune Checkpoint Inhibitors in Combination Therapy
Figure 22. Global Belzutifan Sales Market Share by Combination Therapy in 2026
Figure 23. Global Belzutifan Revenue Market Share by Combination Therapy (2021-2026)
Figure 24. Product Picture of Originator
Figure 25. Product Picture of Generic
Figure 26. Global Belzutifan Sales Market Share by Production Technology in 2026
Figure 27. Global Belzutifan Revenue Market Share by Production Technology (2021-2026)
Figure 28. Belzutifan Consumed in Von Hippel-Lindau (VHL) Disease-Associated Renal Cell Carcinoma (RCC)
Figure 29. Global Belzutifan Market: Von Hippel-Lindau (VHL) Disease-Associated Renal Cell Carcinoma (RCC) (2021-2026) & (Units)
Figure 30. Belzutifan Consumed in Von Hippel-Lindau (VHL) Disease-Associated Central Nervous System Hemangioblastomas
Figure 31. Global Belzutifan Market: Von Hippel-Lindau (VHL) Disease-Associated Central Nervous System Hemangioblastomas (2021-2026) & (Units)
Figure 32. Belzutifan Consumed in Von Hippel-Lindau (VHL) Disease-Associated Pancreatic Neuroendocrine Tumors (pNET)
Figure 33. Global Belzutifan Market: Von Hippel-Lindau (VHL) Disease-Associated Pancreatic Neuroendocrine Tumors (pNET) (2021-2026) & (Units)
Figure 34. Belzutifan Consumed in Pheochromocytoma and Paraganglioma (PPGL) Associated with VHL Disease
Figure 35. Global Belzutifan Market: Pheochromocytoma and Paraganglioma (PPGL) Associated with VHL Disease (2021-2026) & (Units)
Figure 36. Belzutifan Consumed in Otherts
Figure 37. Global Belzutifan Market: Otherts (2021-2026) & (Units)
Figure 38. Global Belzutifan Sale Market Share by Application (2025)
Figure 39. Global Belzutifan Revenue Market Share by Application in 2025
Figure 40. Belzutifan Sales by Company in 2025 (Units)
Figure 41. Global Belzutifan Sales Market Share by Company in 2025
Figure 42. Belzutifan Revenue by Company in 2025 ($ millions)
Figure 43. Global Belzutifan Revenue Market Share by Company in 2025
Figure 44. Global Belzutifan Sales Market Share by Geographic Region (2021-2026)
Figure 45. Global Belzutifan Revenue Market Share by Geographic Region in 2025
Figure 46. Americas Belzutifan Sales 2021-2026 (Units)
Figure 47. Americas Belzutifan Revenue 2021-2026 ($ millions)
Figure 48. APAC Belzutifan Sales 2021-2026 (Units)
Figure 49. APAC Belzutifan Revenue 2021-2026 ($ millions)
Figure 50. Europe Belzutifan Sales 2021-2026 (Units)
Figure 51. Europe Belzutifan Revenue 2021-2026 ($ millions)
Figure 52. Middle East & Africa Belzutifan Sales 2021-2026 (Units)
Figure 53. Middle East & Africa Belzutifan Revenue 2021-2026 ($ millions)
Figure 54. Americas Belzutifan Sales Market Share by Country in 2025
Figure 55. Americas Belzutifan Revenue Market Share by Country (2021-2026)
Figure 56. Americas Belzutifan Sales Market Share by Type (2021-2026)
Figure 57. Americas Belzutifan Sales Market Share by Application (2021-2026)
Figure 58. United States Belzutifan Revenue Growth 2021-2026 ($ millions)
Figure 59. Canada Belzutifan Revenue Growth 2021-2026 ($ millions)
Figure 60. Mexico Belzutifan Revenue Growth 2021-2026 ($ millions)
Figure 61. Brazil Belzutifan Revenue Growth 2021-2026 ($ millions)
Figure 62. APAC Belzutifan Sales Market Share by Region in 2025
Figure 63. APAC Belzutifan Revenue Market Share by Region (2021-2026)
Figure 64. APAC Belzutifan Sales Market Share by Type (2021-2026)
Figure 65. APAC Belzutifan Sales Market Share by Application (2021-2026)
Figure 66. China Belzutifan Revenue Growth 2021-2026 ($ millions)
Figure 67. Japan Belzutifan Revenue Growth 2021-2026 ($ millions)
Figure 68. South Korea Belzutifan Revenue Growth 2021-2026 ($ millions)
Figure 69. Southeast Asia Belzutifan Revenue Growth 2021-2026 ($ millions)
Figure 70. India Belzutifan Revenue Growth 2021-2026 ($ millions)
Figure 71. Australia Belzutifan Revenue Growth 2021-2026 ($ millions)
Figure 72. China Taiwan Belzutifan Revenue Growth 2021-2026 ($ millions)
Figure 73. Europe Belzutifan Sales Market Share by Country in 2025
Figure 74. Europe Belzutifan Revenue Market Share by Country (2021-2026)
Figure 75. Europe Belzutifan Sales Market Share by Type (2021-2026)
Figure 76. Europe Belzutifan Sales Market Share by Application (2021-2026)
Figure 77. Germany Belzutifan Revenue Growth 2021-2026 ($ millions)
Figure 78. France Belzutifan Revenue Growth 2021-2026 ($ millions)
Figure 79. UK Belzutifan Revenue Growth 2021-2026 ($ millions)
Figure 80. Italy Belzutifan Revenue Growth 2021-2026 ($ millions)
Figure 81. Russia Belzutifan Revenue Growth 2021-2026 ($ millions)
Figure 82. Middle East & Africa Belzutifan Sales Market Share by Country (2021-2026)
Figure 83. Middle East & Africa Belzutifan Sales Market Share by Type (2021-2026)
Figure 84. Middle East & Africa Belzutifan Sales Market Share by Application (2021-2026)
Figure 85. Egypt Belzutifan Revenue Growth 2021-2026 ($ millions)
Figure 86. South Africa Belzutifan Revenue Growth 2021-2026 ($ millions)
Figure 87. Israel Belzutifan Revenue Growth 2021-2026 ($ millions)
Figure 88. Turkey Belzutifan Revenue Growth 2021-2026 ($ millions)
Figure 89. GCC Countries Belzutifan Revenue Growth 2021-2026 ($ millions)
Figure 90. Manufacturing Cost Structure Analysis of Belzutifan in 2026
Figure 91. Manufacturing Process Analysis of Belzutifan
Figure 92. Industry Chain Structure of Belzutifan
Figure 93. Channels of Distribution
Figure 94. Global Belzutifan Sales Market Forecast by Region (2027-2032)
Figure 95. Global Belzutifan Revenue Market Share Forecast by Region (2027-2032)
Figure 96. Global Belzutifan Sales Market Share Forecast by Type (2027-2032)
Figure 97. Global Belzutifan Revenue Market Share Forecast by Type (2027-2032)
Figure 98. Global Belzutifan Sales Market Share Forecast by Application (2027-2032)
Figure 99. Global Belzutifan Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Belzutifan
Figure 2. Belzutifan Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Belzutifan Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Belzutifan Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Belzutifan Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Belzutifan Sales Market Share by Country/Region (2025)
Figure 10. Belzutifan Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 40 mg tablets
Figure 12. Product Picture of 120 mg tablets
Figure 13. Global Belzutifan Sales Market Share by Type in 2026
Figure 14. Global Belzutifan Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Hospital
Figure 16. Product Picture of Retail
Figure 17. Product Picture of Online
Figure 18. Global Belzutifan Sales Market Share by Sales Channels in 2026
Figure 19. Global Belzutifan Revenue Market Share by Sales Channels (2021-2026)
Figure 20. Product Picture of With VEGF Inhibitors in Combination Therapy
Figure 21. Product Picture of With Immune Checkpoint Inhibitors in Combination Therapy
Figure 22. Global Belzutifan Sales Market Share by Combination Therapy in 2026
Figure 23. Global Belzutifan Revenue Market Share by Combination Therapy (2021-2026)
Figure 24. Product Picture of Originator
Figure 25. Product Picture of Generic
Figure 26. Global Belzutifan Sales Market Share by Production Technology in 2026
Figure 27. Global Belzutifan Revenue Market Share by Production Technology (2021-2026)
Figure 28. Belzutifan Consumed in Von Hippel-Lindau (VHL) Disease-Associated Renal Cell Carcinoma (RCC)
Figure 29. Global Belzutifan Market: Von Hippel-Lindau (VHL) Disease-Associated Renal Cell Carcinoma (RCC) (2021-2026) & (Units)
Figure 30. Belzutifan Consumed in Von Hippel-Lindau (VHL) Disease-Associated Central Nervous System Hemangioblastomas
Figure 31. Global Belzutifan Market: Von Hippel-Lindau (VHL) Disease-Associated Central Nervous System Hemangioblastomas (2021-2026) & (Units)
Figure 32. Belzutifan Consumed in Von Hippel-Lindau (VHL) Disease-Associated Pancreatic Neuroendocrine Tumors (pNET)
Figure 33. Global Belzutifan Market: Von Hippel-Lindau (VHL) Disease-Associated Pancreatic Neuroendocrine Tumors (pNET) (2021-2026) & (Units)
Figure 34. Belzutifan Consumed in Pheochromocytoma and Paraganglioma (PPGL) Associated with VHL Disease
Figure 35. Global Belzutifan Market: Pheochromocytoma and Paraganglioma (PPGL) Associated with VHL Disease (2021-2026) & (Units)
Figure 36. Belzutifan Consumed in Otherts
Figure 37. Global Belzutifan Market: Otherts (2021-2026) & (Units)
Figure 38. Global Belzutifan Sale Market Share by Application (2025)
Figure 39. Global Belzutifan Revenue Market Share by Application in 2025
Figure 40. Belzutifan Sales by Company in 2025 (Units)
Figure 41. Global Belzutifan Sales Market Share by Company in 2025
Figure 42. Belzutifan Revenue by Company in 2025 ($ millions)
Figure 43. Global Belzutifan Revenue Market Share by Company in 2025
Figure 44. Global Belzutifan Sales Market Share by Geographic Region (2021-2026)
Figure 45. Global Belzutifan Revenue Market Share by Geographic Region in 2025
Figure 46. Americas Belzutifan Sales 2021-2026 (Units)
Figure 47. Americas Belzutifan Revenue 2021-2026 ($ millions)
Figure 48. APAC Belzutifan Sales 2021-2026 (Units)
Figure 49. APAC Belzutifan Revenue 2021-2026 ($ millions)
Figure 50. Europe Belzutifan Sales 2021-2026 (Units)
Figure 51. Europe Belzutifan Revenue 2021-2026 ($ millions)
Figure 52. Middle East & Africa Belzutifan Sales 2021-2026 (Units)
Figure 53. Middle East & Africa Belzutifan Revenue 2021-2026 ($ millions)
Figure 54. Americas Belzutifan Sales Market Share by Country in 2025
Figure 55. Americas Belzutifan Revenue Market Share by Country (2021-2026)
Figure 56. Americas Belzutifan Sales Market Share by Type (2021-2026)
Figure 57. Americas Belzutifan Sales Market Share by Application (2021-2026)
Figure 58. United States Belzutifan Revenue Growth 2021-2026 ($ millions)
Figure 59. Canada Belzutifan Revenue Growth 2021-2026 ($ millions)
Figure 60. Mexico Belzutifan Revenue Growth 2021-2026 ($ millions)
Figure 61. Brazil Belzutifan Revenue Growth 2021-2026 ($ millions)
Figure 62. APAC Belzutifan Sales Market Share by Region in 2025
Figure 63. APAC Belzutifan Revenue Market Share by Region (2021-2026)
Figure 64. APAC Belzutifan Sales Market Share by Type (2021-2026)
Figure 65. APAC Belzutifan Sales Market Share by Application (2021-2026)
Figure 66. China Belzutifan Revenue Growth 2021-2026 ($ millions)
Figure 67. Japan Belzutifan Revenue Growth 2021-2026 ($ millions)
Figure 68. South Korea Belzutifan Revenue Growth 2021-2026 ($ millions)
Figure 69. Southeast Asia Belzutifan Revenue Growth 2021-2026 ($ millions)
Figure 70. India Belzutifan Revenue Growth 2021-2026 ($ millions)
Figure 71. Australia Belzutifan Revenue Growth 2021-2026 ($ millions)
Figure 72. China Taiwan Belzutifan Revenue Growth 2021-2026 ($ millions)
Figure 73. Europe Belzutifan Sales Market Share by Country in 2025
Figure 74. Europe Belzutifan Revenue Market Share by Country (2021-2026)
Figure 75. Europe Belzutifan Sales Market Share by Type (2021-2026)
Figure 76. Europe Belzutifan Sales Market Share by Application (2021-2026)
Figure 77. Germany Belzutifan Revenue Growth 2021-2026 ($ millions)
Figure 78. France Belzutifan Revenue Growth 2021-2026 ($ millions)
Figure 79. UK Belzutifan Revenue Growth 2021-2026 ($ millions)
Figure 80. Italy Belzutifan Revenue Growth 2021-2026 ($ millions)
Figure 81. Russia Belzutifan Revenue Growth 2021-2026 ($ millions)
Figure 82. Middle East & Africa Belzutifan Sales Market Share by Country (2021-2026)
Figure 83. Middle East & Africa Belzutifan Sales Market Share by Type (2021-2026)
Figure 84. Middle East & Africa Belzutifan Sales Market Share by Application (2021-2026)
Figure 85. Egypt Belzutifan Revenue Growth 2021-2026 ($ millions)
Figure 86. South Africa Belzutifan Revenue Growth 2021-2026 ($ millions)
Figure 87. Israel Belzutifan Revenue Growth 2021-2026 ($ millions)
Figure 88. Turkey Belzutifan Revenue Growth 2021-2026 ($ millions)
Figure 89. GCC Countries Belzutifan Revenue Growth 2021-2026 ($ millions)
Figure 90. Manufacturing Cost Structure Analysis of Belzutifan in 2026
Figure 91. Manufacturing Process Analysis of Belzutifan
Figure 92. Industry Chain Structure of Belzutifan
Figure 93. Channels of Distribution
Figure 94. Global Belzutifan Sales Market Forecast by Region (2027-2032)
Figure 95. Global Belzutifan Revenue Market Share Forecast by Region (2027-2032)
Figure 96. Global Belzutifan Sales Market Share Forecast by Type (2027-2032)
Figure 97. Global Belzutifan Revenue Market Share Forecast by Type (2027-2032)
Figure 98. Global Belzutifan Sales Market Share Forecast by Application (2027-2032)
Figure 99. Global Belzutifan Revenue Market Share Forecast by Application (2027-2032)
